Maternal depression, antidepressant prescriptions, and congenital anomaly risk in offspring: a population-based cohort study
OBJECTIVE: To estimate risks of major congenital anomaly (MCA) among children of mothers prescribed antidepressants during early pregnancy or diagnosed with depression but without antidepressant prescriptions. DESIGN: Population-based cohort study. SETTING: Linked UK maternal–child primary care...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Published: |
Wiley
2014
|
| Subjects: | |
| Online Access: | https://eprints.nottingham.ac.uk/31554/ |
| _version_ | 1848794225941938176 |
|---|---|
| author | Ban, Lu Gibson, Jack E. West, Joe Fiaschi, Linda Sokal, Rachel Smeeth, Liam Doyle, P. Hubbard, Richard B. Tata, Laila J. |
| author_facet | Ban, Lu Gibson, Jack E. West, Joe Fiaschi, Linda Sokal, Rachel Smeeth, Liam Doyle, P. Hubbard, Richard B. Tata, Laila J. |
| author_sort | Ban, Lu |
| building | Nottingham Research Data Repository |
| collection | Online Access |
| description | OBJECTIVE: To estimate risks of major congenital anomaly (MCA) among children of mothers prescribed antidepressants during early pregnancy or diagnosed with depression but without antidepressant prescriptions. DESIGN: Population-based cohort study.
SETTING: Linked UK maternal–child primary care records.
POPULATION: A total of 349 127 singletons liveborn between 1990 and 2009.
METHODS: Odds ratios adjusted for maternal sociodemographics and comorbidities (aORs) were calculated for MCAs, comparing women with first-trimester selective serotonin reuptake inhibitors (SSRIs) or tricyclic antidepressants (TCAs) and women with diagnosed but unmedicated depression, or women without diagnosed depression.
MAIN OUTCOME MEASURES: Fourteen system-specific MCA groups classified according to the European Surveillance of Congenital Anomalies and five specific heart anomaly groups. RESULTS: Absolute risks of MCA were 2.7% (95% confidence interval, 95% CI, 2.6–2.8%) in children of mothers without diagnosed depression, 2.8% (95% CI 2.5–3.2%) in children of mothers with unmedicated depression, and 2.7% (95% CI 2.2–3.2%) and 3.1% (95% CI 2.2–4.1%) in children of mothers with SSRIs or TCAs, respectively. Compared with women without depression, MCA overall was not associated with unmedicated depression (aOR 1.07, 95% CI 0.96–1.18), SSRIs (aOR 1.01, 95% CI 0.88–1.17), or TCAs (aOR 1.09, 95% CI 0.87–1.38). Paroxetine was associated with increased heart anomalies (absolute risk 1.4% in the exposed group compared with 0.8% in women without depression; aOR 1.78, 95% CI 1.09–2.88), which decreased marginally when compared with women with diagnosed but unmedicated depression (aOR 1.67, 95% CI 1.00–2.80).
CONCLUSIONS: Overall MCA risk did not increase with maternal depression or with antidepressant prescriptions. Paroxetine was associated with increases of heart anomalies, although this could represent a chance finding from a large number of comparisons undertaken. |
| first_indexed | 2025-11-14T19:12:49Z |
| format | Article |
| id | nottingham-31554 |
| institution | University of Nottingham Malaysia Campus |
| institution_category | Local University |
| last_indexed | 2025-11-14T19:12:49Z |
| publishDate | 2014 |
| publisher | Wiley |
| recordtype | eprints |
| repository_type | Digital Repository |
| spelling | nottingham-315542020-05-04T16:44:57Z https://eprints.nottingham.ac.uk/31554/ Maternal depression, antidepressant prescriptions, and congenital anomaly risk in offspring: a population-based cohort study Ban, Lu Gibson, Jack E. West, Joe Fiaschi, Linda Sokal, Rachel Smeeth, Liam Doyle, P. Hubbard, Richard B. Tata, Laila J. OBJECTIVE: To estimate risks of major congenital anomaly (MCA) among children of mothers prescribed antidepressants during early pregnancy or diagnosed with depression but without antidepressant prescriptions. DESIGN: Population-based cohort study. SETTING: Linked UK maternal–child primary care records. POPULATION: A total of 349 127 singletons liveborn between 1990 and 2009. METHODS: Odds ratios adjusted for maternal sociodemographics and comorbidities (aORs) were calculated for MCAs, comparing women with first-trimester selective serotonin reuptake inhibitors (SSRIs) or tricyclic antidepressants (TCAs) and women with diagnosed but unmedicated depression, or women without diagnosed depression. MAIN OUTCOME MEASURES: Fourteen system-specific MCA groups classified according to the European Surveillance of Congenital Anomalies and five specific heart anomaly groups. RESULTS: Absolute risks of MCA were 2.7% (95% confidence interval, 95% CI, 2.6–2.8%) in children of mothers without diagnosed depression, 2.8% (95% CI 2.5–3.2%) in children of mothers with unmedicated depression, and 2.7% (95% CI 2.2–3.2%) and 3.1% (95% CI 2.2–4.1%) in children of mothers with SSRIs or TCAs, respectively. Compared with women without depression, MCA overall was not associated with unmedicated depression (aOR 1.07, 95% CI 0.96–1.18), SSRIs (aOR 1.01, 95% CI 0.88–1.17), or TCAs (aOR 1.09, 95% CI 0.87–1.38). Paroxetine was associated with increased heart anomalies (absolute risk 1.4% in the exposed group compared with 0.8% in women without depression; aOR 1.78, 95% CI 1.09–2.88), which decreased marginally when compared with women with diagnosed but unmedicated depression (aOR 1.67, 95% CI 1.00–2.80). CONCLUSIONS: Overall MCA risk did not increase with maternal depression or with antidepressant prescriptions. Paroxetine was associated with increases of heart anomalies, although this could represent a chance finding from a large number of comparisons undertaken. Wiley 2014-03-11 Article PeerReviewed Ban, Lu, Gibson, Jack E., West, Joe, Fiaschi, Linda, Sokal, Rachel, Smeeth, Liam, Doyle, P., Hubbard, Richard B. and Tata, Laila J. (2014) Maternal depression, antidepressant prescriptions, and congenital anomaly risk in offspring: a population-based cohort study. BJOG: An International Journal of Obstetrics and Gynaecology, 121 (12). pp. 1471-1481. ISSN 1471-0528 Antidepressants; Congenital anomaly; Depression; SSRIs; TCAs http://onlinelibrary.wiley.com/doi/10.1111/1471-0528.12682/full doi:10.1111/1471-0528.12682 doi:10.1111/1471-0528.12682 |
| spellingShingle | Antidepressants; Congenital anomaly; Depression; SSRIs; TCAs Ban, Lu Gibson, Jack E. West, Joe Fiaschi, Linda Sokal, Rachel Smeeth, Liam Doyle, P. Hubbard, Richard B. Tata, Laila J. Maternal depression, antidepressant prescriptions, and congenital anomaly risk in offspring: a population-based cohort study |
| title | Maternal depression, antidepressant prescriptions, and congenital anomaly risk in offspring: a population-based cohort study |
| title_full | Maternal depression, antidepressant prescriptions, and congenital anomaly risk in offspring: a population-based cohort study |
| title_fullStr | Maternal depression, antidepressant prescriptions, and congenital anomaly risk in offspring: a population-based cohort study |
| title_full_unstemmed | Maternal depression, antidepressant prescriptions, and congenital anomaly risk in offspring: a population-based cohort study |
| title_short | Maternal depression, antidepressant prescriptions, and congenital anomaly risk in offspring: a population-based cohort study |
| title_sort | maternal depression, antidepressant prescriptions, and congenital anomaly risk in offspring: a population-based cohort study |
| topic | Antidepressants; Congenital anomaly; Depression; SSRIs; TCAs |
| url | https://eprints.nottingham.ac.uk/31554/ https://eprints.nottingham.ac.uk/31554/ https://eprints.nottingham.ac.uk/31554/ |